Resorbable biomimetic prosthetic ligament
An artificial ligament prosthesis which is notable in that it comprises a layer totally or partly consisting of PCL fibres. The ligament prosthesis is a biodegradable and “biointegrable” artificial ligament which makes it possible to take away all the apprehensions and uncertainties due to non-degradable synthetic supports. It is a prosthetic structure inspired by and similar to the native tissue, which is biodegradable while being sterilisable. It can optionally be seeded in order to facilitate the formation of functional tissues with controlled cell and tissue activity, having the required mechanical properties. The prosthesis maybe slowly resorbable in order to be gradually replaced with a functional tissue identical to that of the native ligament.
1. An artificial ligament prosthesis comprising:
a surface layer consisting of biodegradable and resorbable fibres onto which a bio-active polymer or copolymer has been grafted, wherein each of said biodegradable and resorbable fibres has a diameter between 1 and 400 μm and consists of a material selected from a group consisting of poly ε-caprolactone (PCL), copolymers of PCL and of lactic acid (L and D), or of glycolic acid, copolymers of glycolic and lactic acids (L and D), polydioxanone, polyhydroxyalcanoate, and copolymers of polydioxanone and polyhydroxyalcanoate.
2. The artificial ligament prosthesis of claim 1 , wherein said biodegradable and resorbable fibres consist of PCL.
3. The artificial ligament prosthesis of claim 1 , wherein said bio-active polymer is poly(styrene sodium sulfonate).
4. The artificial ligament prosthesis of claim 3 , wherein said artificial ligament is an articular or periarticular ligament.
5. The artificial ligament prosthesis of claim 4 , wherein said artificial ligament is an anterior or posterior cruciate ligament.
6. A method for treating the artificial ligament prosthesis of claim 1 , comprising:
grafting a bio-active polymer or copolymer onto biodegradable and resorbable fibres included on a surface of said prosthesis, wherein said grafting step comprises carrying out a peroxidation of the surface by ozonation followed by a radical polymerisation with a solution of at least one monomer.
7. The method of claim 6 , wherein a duration of ozonation using an ozone content of about 50 g/cm 3 is between 5 and 90 minutes.
8. The method of claim 6 , wherein the monomer is styrene sodium sulfonate.
9. The method of claim 6 , wherein the solution of at least one monomer has a concentration in monomer(s) between 5% and k %, where k is a concentration close to the solubility limit of the monomer(s) in the solution.
10. The method of claim 6 , wherein the grafting step is preceded by an additional step of preparing the surface in a solvent medium only, or preparing the surface in a solvent medium followed by an aqueous medium.
11. The method of claim 10 , wherein the solvent medium comprises hexane or ethyl ether.
12. The method of claim 10 , wherein the solvent medium comprises at least one solvent able to modify the surface via swelling.
13. The method of claim 12 , wherein the solvent able to modify the surface via swelling is tetrahydrofuran (THF).
14. The method of claim 12 , wherein the solvent able to modify the surface via swelling is selected from the following group of solvents: tetrahydrofuran (THF), dimethylsulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMA), N-methylpyrrolidone (NMP).
15. The method of claim 10 , wherein the step of preparing the surface in an aqueous medium comprises hot-treating the surface with an aqueous solution of alkaline or alkaline earth metal carbonate salts.
16. The method of claim 6 , further comprising an additional step of impregnating the prosthesis, after the grafting step, by at least one biochemical agent that favors colonization of fibroblasts.
17. The method of claim 16 , wherein the biochemical agent is a protein of the family of fibronectins and/or type I and/or III collagen.